Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7618817 Genetically modified human natural killer cell lines

Patent 7618817 was granted and assigned to Fox Chase Cancer Center (company) on November, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12109238 Chimeric antigen receptor-modified NK-92 cells
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12065492 Anti-B7-H6 antibody, fusion proteins, and methods of using the same
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064450 Tumoricidal and antimicrobial compositions and methods
0
Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits on 8 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11975027 Tumoricidal and antimicrobial compositions and methods
0
Edits on 9 Feb, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11890348 Localized delivery of anti-fugetactic agent for treatment of cancer
0
Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits on 4 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Jan, 2024
Edits on 3 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jan, 2024
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11850262 Compositions and methods for CAR T cell therapy
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834676 T cell receptor-deficient T cell compositions
0
Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11788059 Modified NK-92 cells for treating cancer
Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11779602 Methods of use for CAR T cells
Edits on 20 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 20 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11759480 Compositions and methods for CAR T cell therapy
Edits on 17 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 17 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Kerry S. Campbell0
Edits on 16 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Article (+517 characters)
Article

Patent abstract

The invention provides a natural killer cell, NK-92, modified to express an Fc receptor on the surface of the cell, such as CD16 (FcγRIII-A), or other Fcγ or Fc receptors. The modified NK-92 cell can be further modified to concurrently express an associated accessory signaling protein, such as FcεRI-γ, TCR-ζ, or to concurrently express interleukin-2 (IL-2) or other cytokines. Additional methods are disclosed for various assays, assessments, and therapeutic treatments with the modified NK-92 cells.

Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11753625 Modified NK-92 haNK003 cells for the clinic
Edits on 28 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Jun, 2023
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=076188170
Edits on 18 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07618817 Genetically modified human natural killer cell lines US Patent 7618817 Genetically modified human natural killer cell lines

Infobox
Patent Number
076188170
Patent Number
76188170

Find more entities like US Patent 7618817 Genetically modified human natural killer cell lines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo